More on Pharmacy

Here are the latest updates on the COVID-19 vaccine distribution

This is our continuing coverage of the steps being taken to get every American inoculated against the coronavirus.

The millions of Americans who have yet to receive a COVID-19 vaccine can expect to be eligible two weeks earlier than originally thought, as President Biden is expected to update his eligibility deadline today, according to CNN.

President Biden is scheduled to give remarks on the state of vaccinations today where he will announce that every adult in the country will be eligible to be vaccinated by April 19, according to White House press secretary Jen Psaki.

"The President will announce officially later this afternoon that we've reached 150 million shots in arms since entering government and that by April 19 all adult Americans will be eligible to get the vaccine," Psaki said during a White House briefing.

"That doesn't mean they will get it that day – it means they can join the line that day if they have not already done that beforehand. It means that everybody will be eligible to go to their local pharmacy, go to their community health center, mobile vaccination site, mass vaccination site on the date and moving forward."

The new deadline means U.S. adults will be eligible two weeks sooner than President Biden's original May 1 deadline.

Additionally, President Biden is expected to announce today that 150 million doses of the vaccine have been administered since he took office. This falls in line with his goal of administering 200 million shots by his 100th day in office, CNN reported.

In total, 167 million doses of the vaccine have been administered, equaling 18.8% of the total population that is fully vaccinated, according to data from the Centers for Disease Control and Prevention.

See our continuing vaccine coverage here:

A look at the pandemic's effect on supply chain, with McKesson's Craig Dolan

Pfizer releases new vaccine efficacies, while J&J vaccine shipments get delayed

Vaccines and prior COVID-19 infection offer protection against variants

AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial

AstraZeneca vaccine shows 79% efficacy in phase III trial

Providers get greater reimbursement for COVID-19 vaccine

Big shift seen in high-risk older adults' attitudes toward COVID-19 vaccination

CVS Health expands COVID-19 vaccine offerings to 29 states

CDC relaxes COVID-19 restrictions as more Americans get vaccinated

$250 million in COVID-19 grants aim to vaccinate underserved populations

Health insurers commit to helping seniors receive the COVID-19 vaccine

Merck to open facilities to Johnson & Johnson for speedier COVID-19 vaccine production 

FDA issues emergency use authorization for Johnson & Johnson COVID-19 vaccine

Biden signs executive order to spur domestic supply chain

Human rights law can provide a fair, transparent framework for vaccine allocations

FDA deems Johnson & Johnson COVID-19 vaccine safe and effective

CVS Health to expand vaccine efforts in Florida

CVS Health, Lyft and YMCA team for equitable access to a COVID-19 vaccination site

AHIP launches resource page dedicated to COVID-19 vaccines

New COVID-19 model shows little benefit in vaccinating high-risk individuals first

Biden issues 5 executive orders to ramp up COVID-19 vaccine and supply response

Federal government tells states not to hold vaccine in reserve for second dose

HHS releases $22 billion for testing and vaccinations 

AHA urges HHS to better coordinate COVID-19 vaccine rollout

CVS Health administering COVID-19 vaccine at skilled nursing facilities in 49 states

Moderna vaccine shows 94.1% efficacy in a Phase 3 clinical trial

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines

Phase 3 trial of Novavax investigational COVID-19 vaccine opens

Confusion about flu shot, efficacy of COVID-19 vaccines may slow adoption

Smart temp control technology could be key for COVID-19 vaccine rollout

CareFirst BlueCross BlueShield to cover all costs for COVID-19 vaccines

U.S. government agrees to purchase 100 million additional Pfizer vaccines

Close to 8 million doses of two COVID-19 vaccines are going out this week

Moderna vaccine rolls out amid miscommunication over Pfizer doses and new virus strain

Walgreens begins administering the COVID-19 vaccine in select states

FDA advisory committee approves Moderna vaccine for emergency use authorization

FDA advisory committee today is expected to scrutinize Moderna on vaccine reaction

Pharmacy giants ramp up logistical assistance for COVID-19 vaccine rollout

CDC is giving $227 million for COVID-19 vaccine preparedness and tracking

More than half unlikely to get COVID-19 vaccine under emergency use authorization

HHS purchases 100 million additional doses of Moderna investigational COVID-19 vaccine

Pfizer-BioNTech vaccine rolls out to frontline healthcare workers

FDA to 'rapidly work' towards emergency use authorization for Pfizer-BioNTech vaccine

Pfizer-BioNTech vaccine gets FDA advisory committee approval

Thousands in the United Kingdom are the first to receive Pfizer COVID-19 vaccine

Eli Lilly and UnitedHealth Group partner on COVID-19 antibody treatment for high-risk individuals

Operation Warp Speed is looking to start distributing COVID-19 vaccine by mid-month

Moderna seeks regulatory authorization for its COVID-19 vaccine

HHS will begin allocating Regeneron's COVID-19 therapeutic this week

HHS partners with chain and independent pharmacies to increase access to future COVID-19 vaccines

COVID-19 vaccine distribution will begin within 24 hours of an emergency use authorization

Moderna vaccine candidate shows 94.5% efficacy against COVID-19

Pfizer touts new COVID-19 vaccine, calling it '90% effective'

Medicare beneficiaries can get monoclonal antibody COVID-19 treatments at no cost

FDA grants emergency use authorization for Eli Lilly antibody treatment for COVID-19

Twitter: @SusanJMorse
Email the writer: